7-(6-Chloro-2-methylpyrimidin-4-yl)-2-oxa-7-azaspiro[3.5]nonane

Catalog No.: 
ACVDOA249
CAS No.: 
2098090-92-5
Molecular Formula: 
C12H16ClN3O
Molecular Weight: 
253.73
7-(6-Chloro-2-methylpyrimidin-4-yl)-2-oxa-7-azaspiro[3.5]nonane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(6-Chloro-2-methylpyrimidin-4-yl)-2-oxa-7-azaspiro[3.5]nonane
IUPAC Name7-(6-chloro-2-methylpyrimidin-4-yl)-2-oxa-7-azaspiro[3.5]nonane
MDL No.MFCD29996696
Molecular FormulaC12H16ClN3O
Molecular Weight253.73
SMILESCC1=NC(Cl)=CC(N(CC2)CCC32COC3)=N1
InChI KeyLVUNPGWORXIYMQ-UHFFFAOYSA-N
Synonym7-(6-Chloro-2-methylpyrimidin-4-yl)-2-oxa-7-azaspiro[3.5]nonane;2-Oxa-7-azaspiro[3.5]nonane, 7-(6-chloro-2-methyl-4-pyrimidinyl)-
CAS No.2098090-92-5

Synthetic Route by SureRoute

1. ACVDOA249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIVDR359 route compound structure diagram
    ACIVDR3591257381-44-4In Stock
  2. Plus
  3. ACFUEM270 route compound structure diagram
    ACFUEM2701780-26-3In Stock
  4. Then
  5. ACVDOA249 route product structure diagram
    ACVDOA2492098090-92-5
Inquiry

2. ACVDOA249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIVDR359 route compound structure diagram
    ACIVDR3591257381-44-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVDOA249 route product structure diagram
    ACVDOA2492098090-92-5
Inquiry

3. ACVDOA249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIVDR359 route compound structure diagram
    ACIVDR3591257381-44-4In Stock
  2. Plus
  3. ACBQPE592 route compound structure diagram
    ACBQPE59217551-52-9In Stock
  4. Then
  5. ACVDOA249 route product structure diagram
    ACVDOA2492098090-92-5
Inquiry

Comments (0)